Skip to Content

KRC KRC (Cefaclor 250 mg)

Pill with imprint KRC KRC is Blue & Pink, Capsule-shape and has been identified as Cefaclor 250 mg. It is supplied by Alvogen, Inc..

Cefaclor is used in the treatment of otitis media; bladder infection; kidney infections; bronchitis; pneumonia and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefaclor 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KRC KRC

Cefaclor 250 mg KRC KRC
Cefaclor 250 mg KRC KRC
Cefaclor 250 mg KRC KRC


250 mg
Blue & Pink
18.00 mm
Prescription only
Drug Class
Second generation cephalosporins
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen, Inc.
Inactive Ingredients
magnesium stearate, lactose monohydrate, magnesium silicate, sodium glycolate, gelatin, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 3

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
47781-0266 Alvogen, Inc.
61442-0171 Carlsbad Technology, Inc.

Get help with Imprint Code FAQs.

Related Images for "KRC KRC"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.